Literature DB >> 12830548

[Mucinous adenocarcinoma of the bladder].

J L Palmero Martí1, J A Queipo Zaragozá, M A Bonillo García, A Budía Alba, F J Vera Sempere, J F Jiménez Cruz.   

Abstract

Mucinous adenocarcinoma is a rare entity within the group of primary adenocarcinoma of the bladder which represent 0.5-2% of all malignant epithelial bladder tumours. In spite of the rarity of this tumoral type; it is a poor prognosis entity mainly due to its diagnosis especially in advanced stage of the disease. There is no general agreement on the treatment of adenocarcinoma of bladder. Not withstanding surgery would be the only curative treatment, although unfortunately, it is curative in just a few cases. We report six cases with mucinous adenocarcinoma of the bladder attended in our Department in the last ten years (january 1991-december 2001). In one of them a radical cystectomy was performed, while transurethral resection with or without adjuvant treatment was practiced in the other one. Only one patient is alive today, namely, the one where the tumour not invade the muscular tissue. These findings show the discouraging results of this entity closely intertwined with the pathologic stage.

Entities:  

Mesh:

Year:  2003        PMID: 12830548     DOI: 10.1016/s0210-4806(03)72920-9

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  3 in total

1.  Mucinous Bladder Adenocarcinoma: Case Report and Literature Review.

Authors:  Bruno Mello R Santos; Julia Duarte de Souza; Rachel Silviano Brandão Correa Lima; Enaldo Melo de Lima
Journal:  Case Rep Urol       Date:  2015-09-01

2.  Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review.

Authors:  Dawei Wang; Keping Zhang; Lihui Guan; Nuan Wen
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

3.  Mucinous adenocarcinoma of the urinary bladder.

Authors:  Giulio Baffigo; Giampaolo Delicato; Daniele Bianchi; Stefano Signore; Edoardo Tartaglia; Francesco Corvese; Alessandro Perla; Bonaventura Marino; Giuseppe Santeusanio; Vincenzo Ferdinandi
Journal:  Am J Case Rep       Date:  2012-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.